Last updated on

Frontiers of Hormone Research
Research Hotspot & Journal Scope - Hyperparathyroidism


Frontiers of Hormone Research - DOI: 10.1159/000491037
Familial and Hereditary Forms of Primary Hyperparathyroidism.

F Cetani · F Saponaro · S Borsari · C Marcocci ·

Medicine
PDF
Frontiers of Hormone Research - DOI: 10.1159/000491041
Secondary and Tertiary Hyperparathyroidism.

Piergiorgio Messa · Carlo Maria Alfieri ·

Medicine
PDF
Frontiers of Hormone Research - DOI: 10.1159/000491035
Asymptomatic Primary Hyperparathyroidism.

Bart L Clarke ·

Biology Medicine
PDF
Frontiers of Hormone Research - DOI: 10.1159/000491038
Familial Hypocalciuric Hypercalcemia and Neonatal Severe Hyperparathyroidism.

Letizia Vannucci · Maria Luisa Brandi ·

Biology Medicine
PDF
Frontiers of Hormone Research - DOI: 10.1159/000491034
Primary Hyperparathyroidism.

Laura Masi ·

Medicine
PDF

Objective Tertiary hyperparathyroidism, an autonomous hyperproduction of parathyroid hormone (PTH), has a challenge in its treatment.

Pattern of Intraoperative Parathyroid Hormone and Calcium in the Treatment of Tertiary Hyperparathyroidism [10.1177/0194599819866819]


It is estimated that up to 90% of patients with chronic kidney disease develop secondary hyperparathyroidism (sHPT).

The Value of Imaging of the Parathyroid Glands in Secondary Hyperparathyroidism. [10.21614/chirurgia.114.5.541]


At present, the diagnosis and treatment standard of asymptomatic primary hyperparathyroidism is still controversial, This article is based on Guidelines for the management of asymptomatic primary hyperparathyroidism in 2014 and sharing the latest research progress to proved some suggestions for improving the medical management of asymptomatic primary hyperparathyroidism patients and improving the quality of life of them.

Clinical characteristics, diagnosis and treatment measures of asymptomatic primary hyperparathyroidism [10.3760/CMA.J.ISSN.1673-4106.2019.06.009]


Medications that treat persistent hyperparathyroidism include vitamin D, vitamin D analogues, and calcimimetics.

Management of Post-transplant Hyperparathyroidism and Bone Disease [10.1007/s40265-019-01074-4]


An open label, prospective pilot clinical study of denosumab for severe hyperparathyroidism in patients with low bone mass undergoing dialysis.

SAT-509 Denosumab Use in Tertiary Hiperparathyroidism with Fracture [10.1210/JS.2019-SAT-509]



Research Hotspot

Frontiers of Hormone Research

Research Hotspot
Frontiers of Hormone Research Related Journals

Popular Journals